Dr. Samir S. Taneja

Dr. Samir S. Taneja, MD, is a nationally recognized urologic oncologist specializing in the diagnosis and treatment of prostate, kidney, and bladder cancers. He serves as System Chair of Urology and Senior Vice President at Northwell Health, where he leads the Smith Institute for Urology and oversees the integration of urologic services across the health system. Prior to joining Northwell, Dr. Taneja spent nearly three decades at NYU Langone Health, where he held leadership roles including Vice Chair of Urology and Director of Urologic Oncology. He earned his medical degree from Northwestern University Feinberg School of Medicine and completed his residency in urology at UCLA Medical Center. He is board-certified in Urology.

Dr. Taneja is widely recognized for pioneering the use of MRI-targeted biopsy and focal therapy in the management of prostate cancer. His work has helped redefine prostate cancer diagnostics and introduced less invasive treatment strategies that preserve organ function and quality of life. He has authored over 200 peer-reviewed publications and several textbooks, including serving as editor of a leading reference on urologic surgical complications. His research has contributed significantly to clinical practice guidelines and to innovations in image-guided interventions for urologic malignancies.

In addition to his clinical and research achievements, Dr. Taneja is a committed educator and institutional leader. He has mentored numerous residents, fellows, and junior faculty, and plays an active role in shaping multidisciplinary cancer programs and men’s health initiatives. He is a member of the American Urological Association and the Society of Urologic Oncology, and continues to lead efforts to standardize and elevate urologic care across large health systems. Through his commitment to academic excellence, innovation, and integrated cancer care, Dr. Taneja remains a driving force in the field of urologic oncology.